IL10 and carcinoma: M2-type TAMs, on the contrary, secrete anti-inflammatory agents such as transforming growth factor-β (TGF-β), interleukin-10 (IL-10), and epidermal growth factor, which inhibit immune responses and induce angiogenesis and carcinoma metastasis [22].